Article

Investigation of positron emission tomography for pharmacological assessment of epidermal growth factor receptor-directed therapies

2013-01-01

Abstract excerpt

The epidermal growth factor receptor (EGFR) is overexpressed in many cancers including lung, breast, head and neck and brain. Furthermore, mutations of this receptor have been shown to play crucial roles in response to EGFR-targeted therapies in non small cell lung carcinoma (NSCLC) patients. Imaging EGFR or its function using positron emission tomography (PET) could aid in selection and monitoring patient’s thera...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 0eda543d-79f3-51ec-838a-5a81bbc58cd5
DOI: 10.25560/18660

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Investigation of positron emission tomography for pharmacological assessment of epidermal growth factor receptor-directed therapiesDOI 10.25560/18660Read

A PET imaging approach for determining EGFR mutation status for improved lung cancer patient management.Semantic proximity Read

Monitoring of gefitinib sensitivity with radioiodinated PHY based on EGFR expression.Semantic proximity Read

PET and SPECT Imaging of the EGFR Family (RTK Class I) in OncologySemantic proximity Read

Molecular imaging of active mutant L858R EGF receptor (EGFR) kinase-expressing nonsmall cell lung carcinomas using PET/CT.Semantic proximity Read

A Novel Dual-labeled Peptide for Multimodal Imaging of EGFR with L858R Mutation.Semantic proximity Read

Synthesis and Fundamental Evaluation of Radioiodinated Rociletinib (CO-1686) as a Probe to Lung Cancer with L858R/T790M Mutations of Epidermal Growth Factor Receptor (EGFR).Semantic proximity Read

⁹⁹mTc-HYNIC-MPG: a novel SPECT probe for targeting mutated EGFR.Semantic proximity Read

Design and Evaluation of EGFR-Targeted Near-Infrared Fluorescent Probes for Selective Tumor Cell ImagingSemantic proximity Read

Molecular tracers for the PET and SPECT imaging of diseaseSemantic proximity Read

Evaluation of 99mTc-HYNIC-MPG as a novel SPECT radiotracer to detect EGFR-activating mutations in NSCLC.Semantic proximity Read

Pharmacokinetic analysis of 6-O-[18F]FEE for PET imaging of EGFR mutation.Semantic proximity Read

Development and Preliminary Evaluations of a Novel 18F-Labeled Tracer for Detection of BRAFV600E Mutant Status in Animal Models of Melanoma.Semantic proximity Read